Below are the issue highlights and Editor Picks for the April issue of JDD!
Observational Study of Clindamycin Phosphate and Tretinoin Gel for the Treatment of Acne shows improvement in both facial acne and quality of life.
The addition of Apremilast to topical therapy significantly improves moderate plaque plaque-type psoriasis in Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy.
Adjuvant topical therapy aids the outcome of non-invasive fat reduction procedures in A Double-Blind Randomized Controlled Trial Evaluating the Efficacy and Tolerability of a Topical Body Treatment in Combination With Cryolipolysis Procedures.
A Randomized Controlled Tolerability Study to Evaluate Reformulated Benzoyl Peroxide Face Washes for Acne Vulgaris is consistent with the known effects of topical BPO application.
The Effect of Calcipotriene-Betamethasone Dipropionate Aerosol Foam versus Vehicle on Target Lesions in Moderate Severity Plaque Psoriasis: Focus on Elbows and Knees reports outcomes from an open-phase design study.
Patented protein mix improves the signs of aging in Red Deer Umbilical Cord Lining Mesenchymal Stem Cell Extract Cream for Rejuvenation of the Face.
An Open Label Study of an Occlusive Heat Patch in the Treatment of Warts shows excellent results in the treatment of warts.
A novel approach for facilitation and hastening recovery after non-surgical fat removal is shown in Non-Surgical Fat Reduction and Topical Modulation of Adipose Tissue Physiology.
A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Azelaic Acid Foam for Rosacea finds minimal patient concerns with monotherapy.
Improvement of psoriasis is seen in Treatment of Psoriasis With Biologics and Apremilast in Patients With a History of Malignancy: A Retrospective Chart Review.
Grover’s Disease Treated With Total Skin Electron Beam Radiotherapy shows improvement in recalcitrant Grover’s disease.
Use of biologic combination therapy in hard to treat plaque-type psoriasis is described in Successful Treatment of Refractory Plaque-Type Psoriasis and Psoriatic Arthritis With Guselkumab and Adalimumab Combination Therapy: A Case Report.